High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.

MLA

Gazzaruso, Carmine, et al. “High Prevalence of Antinuclear Antibodies and Lupus Anticoagulant in Patients Hospitalized for SARS-CoV2 Pneumonia.” Clinical Rheumatology, vol. 39, no. 7, July 2020, pp. 2095–97. EBSCOhost, https://doi.org/10.1007/s10067-020-05180-7.

APA

Gazzaruso, C., Carlo Stella, N., Mariani, G., Nai, C., Coppola, A., Naldani, D., & Gallotti, P. (2020). High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clinical Rheumatology, 39(7), 2095–2097. https://doi.org/10.1007/s10067-020-05180-7

Chicago

Gazzaruso, Carmine, Nicoletta Carlo Stella, Giuseppe Mariani, Carlo Nai, Adriana Coppola, Daniela Naldani, and Pietro Gallotti. 2020. “High Prevalence of Antinuclear Antibodies and Lupus Anticoagulant in Patients Hospitalized for SARS-CoV2 Pneumonia.” Clinical Rheumatology 39 (7): 2095–97. doi:10.1007/s10067-020-05180-7.